DAVITA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.5 USD | -0.30% |
|
+2.28% | +31.27% |
| May. 07 | TD Cowen Adjusts Price Target on DaVita to $139 From $136 | MT |
| May. 03 | UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating | MT |
Chart calendar DaVita Inc.
3d0be35b0775dec.DojsB7t6RS2JCg9M1nWt9P5UFLtApuf51QLv0U33cZY.OterbvwYIADYYGIkrznDw4okY_Z5ya2NgmaMs3iGIPw_x4hKgzYTH_tkNw~a52460290c8faa37ec0b47476ea3468b
Upcoming events on DaVita Inc.
Past events on DaVita Inc.
| 2024-05-02 05:00 pm | Q1 2024 Earnings Call |
| 2024-05-02 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-13 08:00 am | Barclays Global Healthcare Conference |
| 2024-03-04 11:10 am | TD Cowen Health Care Conference |
| 2024-02-13 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-13 04:08 pm | Q4 2023 Earnings Release |
| 2023-11-07 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-03 05:30 pm | American Society of Nephrology Kidney Meeting |
| 2023-09-14 11:30 am | UBS Conference |
| 2023-08-03 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-06 12:00 pm | Annual General Meeting |
| 2023-05-10 04:40 pm | Bank of America Healthcare Conference |
| 2023-05-08 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-08 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-14 03:05 pm | Barclays Global Healthcare Conference |
| 2023-02-22 05:00 pm | FY 2022 Earnings Call |
| 2023-02-22 04:05 pm | FY 2022 Earnings Release |
| 2022-11-01 | American Society of Nephrology Kidney Week Conference - Temporal Relationship Between Prior Estimate |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 388 11 412 -0.21% | 11 551 11 576 -0.22% | 11 619 11 595 0.21% | 11 610 11 626 -0.14% | 12 140 12 003 1.14% | 12 689 |
|
EBITDA Million USD | Released Forecast Spread | 2 383 2 353 1.3% | 2 376 2 400 -1% | 2 478 2 482 -0.18% | 2 072 2 079 -0.37% | 2 479 2 381 4.14% | 2 630 |
|
EBIT Million USD | Released Forecast Spread | 1 768 1 762 0.37% | 1 746 1 788 -2.38% | 1 797 1 787 0.58% | 1 339 1 379 -2.86% | 1 734 1 651 5.01% | 1 941 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 195 1 160 3.09% | 1 318 1 345 -1.97% | 1 518 1 397 8.72% | 966 857 12.76% | 1 177 964 22.14% | 1 258 |
|
Net income Million USD | Released Forecast Spread | 811 760 6.68% | 774 824 -6.16% | 978 975 0.39% | 560 584 -4.01% | 692 682 1.47% | 775 |
|
EPS USD | Released Forecast Spread | 5,27 5,06 4.24% | 6,31 6,72 -6.16% | 8,90 8,84 0.72% | 5,85 6,08 -3.84% | 7,42 7,38 0.54% | 8,91 |
| Announcement Date | 10/02/20 | 11/02/21 | 10/02/22 | 22/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 818 2 888 -2.45% | 2 927 2 934 -0.26% | 2 949 2 977 -0.95% | 2 917 2 931 -0.49% | 2 873 2 837 1.27% | 3 000 2 952 1.66% | 3 121 3 017 3.46% | 3 146 3 007 4.62% | 3 071 3 021 1.65% | 3 155 | 3 231 | 3 246 | 3 156 | 3 211 |
|
EBITDA Million USD | Released Forecast Spread | 511 562 -8.99% | 604 587 2.93% | 506 548 -7.56% | 450 453 -0.64% | 530 479 10.63% | 616 567 8.67% | 713 611 16.78% | 610 556 9.78% | 650 588 10.57% | 676 | 699 | 638 | 674 | 723 |
|
EBIT Million USD | Released Forecast Spread | 338 388 -12.72% | 433 414 4.56% | 312 368 -15.3% | 256 274 -6.33% | 352 303 16.14% | 432 392 10.34% | 525 432 21.55% | 415 383 8.29% | 463 415 11.53% | 499 | 526 | 468 | 499 | 538 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 263 267 -1.6% | 349 263 32.64% | 207 269 -23.01% | 147 129 14.34% | 215 190 13.04% | |||||||||
|
Net income Million USD | Released Forecast Spread | 162 191 -15.27% | 225 203 10.73% | 105 166 -36.5% | 68,1 80,5 -15.43% | 116 111 4.28% | 179 143 24.98% | 247 172 43.07% | 151 129 16.61% | 240 188 27.41% | 216 | 215 | 190 | 207 | |
|
EPS USD | Released Forecast Spread | 1,61 1,87 -13.9% | 2,30 2,07 11.29% | 1,13 1,73 -34.75% | 0,74 0,88 -15.43% | 1,25 1,20 3.99% | 1,91 1,55 23.23% | 2,62 1,85 41.62% | 1,62 1,42 14.08% | 2,65 2,07 28.02% | 2,42 | 2,45 | 2,20 | 2,43 | |
| Announcement Date | 05/05/22 | 01/08/22 | 28/10/22 | 22/02/23 | 08/05/23 | 03/08/23 | 07/11/23 | 13/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for DaVita Inc.
| 2024-05-10 07:00 am | DENTALCORP HOLDINGS LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | CHULARAT HOSPITAL: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:20 pm | AMN HEALTHCARE SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | NATERA, INC.: Q1 2024 Earnings Release |
| 2024-05-09 06:50 am | SOLVENTUM CORPORATION: Q1 2024 Earnings Release |
| 2024-05-09 06:00 am | LIFESTANCE HEALTH GROUP, INC.: Q1 2024 Earnings Release |
| 2024-05-09 06:00 am | PRIVIA HEALTH GROUP, INC.: Q1 2024 Earnings Release |
| 2024-05-08 07:00 am | WELL HEALTH TECHNOLOGIES CORP.: Q1 2024 Earnings Release |
| 2024-05-08 07:00 am | R1 RCM INC.: Q1 2024 Earnings Release |
| 2024-05-07 | RHÖN-KLINIKUM AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DVA Stock
- Calendar DaVita Inc.